title: Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era.
authors.affiliation: *Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA; †Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and ‡Futures Institute, Glastonbury, CN.
authors.forename: Paul G
authors.initials: PG
authors.lastname: Farnham
authors.forename: David R
authors.initials: DR
authors.lastname: Holtgrave
authors.forename: Chaitra
authors.initials: C
authors.lastname: Gopalappa
authors.forename: Angela B
authors.initials: AB
authors.lastname: Hutchinson
authors.forename: Stephanie L
authors.initials: SL
authors.lastname: Sansom
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D009010:Monte Carlo Method; D019057:Quality-Adjusted Life Years; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents